Collecting bio-specimens from high-risk patients for pancreatic cancer detection
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
This study is trying to collect samples from people with pancreatic cysts and those at high risk for pancreatic cancer to see if they can find early signs of the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Stanford, California) |
| Trial ID | NCT03260842 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a bio-repository by collecting bio-specimens from two groups of patients: those diagnosed with pancreatic cysts and individuals identified as high risk for pancreatic cancer due to family history or genetic mutations. The study will gather pancreatic cyst fluid and blood samples using standardized protocols to facilitate early detection of pancreatic cancer. By analyzing these specimens, researchers hope to identify potential biomarkers that could lead to improved screening and diagnosis of this aggressive disease.
Who should consider this trial
Good fit: Ideal candidates include individuals over 18 years old with pancreatic cysts or those at high risk for pancreatic cancer due to genetic factors or family history.
Not a fit: Patients who are unable to provide consent or unwilling to donate bio-specimens will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance early detection methods for pancreatic cancer, potentially leading to better patient outcomes.
How similar studies have performed: Other studies focusing on early detection and biomarker identification for pancreatic cancer have shown promise, indicating that this approach is both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Older than 18 with pancreas cyst * Older than 18 at high risk for Pancreas cancer Exclusion Criteria: * Unable to provide consent * Not willing to provide bio-specimens
Where this trial is running
Stanford, California
- Stanford University — Stanford, California, United States (Recruiting)
Study contacts
- Principal investigator: Walter Park, MD — Faculty
- Study coordinator: Walter Park, MD
- Email: wgpark@stanford.edu
- Phone: 650-723-4102
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.